A new research paper was published in Oncotarget (Volume 16) on November 6, 2025, titled “Anti-DNA virus agent cidofovir – loaded green synthesized cerium oxide nanoparticles (Nanoceria): Nucleic ...
The market is projected to scale rapidly—from USD 1,029 million in 2025 to USD 5,765 million by 2035—representing a swift ...
Moligo Technologies, a DNA synthesis company advancing gene therapies, announced today the publication of an article in Nature Communications that demonstrates enzymatically synthesized ...
In a recent study published in Current Research in Immunology, researchers analyzed the characteristics of coronaviruses (CoVs) and novel CoV vaccine candidates. Seven known CoVs can infect humans.
Moligo and Cellectis show promise for enzymatic ssDNA in non-viral gene editing: Stockholm Monday, November 24, 2025, 15:00 Hrs [IST] Moligo Technologies, a DNA synthesis company ...
Philadelphia, July 15, 2024 – Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers from Children’s Hospital of ...
Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers demonstrated that mitochondrially-targeted antioxidants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback